Myriad Genetics Inc. (MYGN)
NASDAQ: MYGN
· Real-Time Price · USD
5.00
0.08 (1.63%)
At close: Jun 17, 2025, 10:13 AM
Myriad Genetics Revenue
Myriad Genetics reported an annual revenue of $753.2M, reflecting a 11.03% growth. For the quarter ending September 30, 2024, Myriad Genetics generated $213.3M in revenue.
Revenue (ttm)
$753.2M
Revenue Growth
11.03%
Price / Sales Ratio
2.1
Revenue / Employee
$278.96K
Employees
2,700
Market Cap
460.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|